Literature DB >> 11126268

Hepatic O2 exchange and liver energy metabolism in hyperdynamic porcine endotoxemia: effects of iloprost.

K Träger1, M Matejovic, C Zülke, A Vlatten, J Vogt, U Wachter, J Altherr, A Brinkmann, K W Jauch, M Georgieff, P Radermacher.   

Abstract

OBJECTIVE: To compare the effects of a 12 h continuous infusion of iloprost, a stable prostacyclin analogue, on hepatic blood flow (Qliv), O2 exchange, and energy metabolism during a 24 h hyperdynamic, porcine endotoxemia with volume resuscitation alone.
DESIGN: Prospective, randomized, experimental study with repeated measures.
SETTING: Investigational animal laboratory.
SUBJECTS: Twenty-eight domestic pigs: 16 animals during endotoxemia with volume resuscitation alone (ETX), 12 with endotoxemia, volume resuscitation, and treatment with iloprost (ILO).
INTERVENTIONS: Endotoxemia was initiated by continuous infusion of E. coli lipopolysaccharide. Animals were resuscitated with hetastarch, aimed at maintaining a MAP of > 60 mmHg. After 12 h of endotoxemia, iloprost was administered for 12 h in the treatment group, titrated to avoid pharmacologically induced hypotension (MAP < 60 mmHg). MEASUREMENTS AND
RESULTS: Iloprost significantly increased Qliv, with no effect on hepatic O2 delivery. Mean capillary hemoglobin O2 saturation (HbScO2) on the liver surface, as well as HbScO2 frequency distributions--a measure of microcirculatory O2 availability--remained unchanged. Treatment with iloprost, however, significantly attenuated the endotoxin-induced derangements of cellular energy metabolism as reflected by the diminished progressive decrease in hepatic lactate uptake rate and a blunted increase in hepatic venous lactate/pyruvate ratios. While endotoxin significantly increased endogenous glucose production (EGP) rate, iloprost restored EGP to normal at the end of the experiment.
CONCLUSIONS: Thus, in a clinically relevant model of human sepsis, iloprost did not produce potential adverse effects but rather ameliorated hepatic metabolic disturbances and, thereby, hepatic energy balance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11126268     DOI: 10.1007/s001340000645

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  6 in total

1.  Is there a place for prostacyclin in the treatment of septic shock?

Authors:  D De Backer
Journal:  Intensive Care Med       Date:  2001-07       Impact factor: 17.440

2.  Opposite effects of prostacyclin on hepatic blood flow and oxygen consumption after burn and sepsis.

Authors:  Tamer Tadros; Daniel L Traber; David N Herndon
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

3.  Validation of portal vein flow measurement by color flow Doppler sonography in a porcine model of septic shock.

Authors:  Carl Zülke; Martin Matejovic; Karl Träger; Peter Radermacher
Journal:  Intensive Care Med       Date:  2005-08-16       Impact factor: 17.440

Review 4.  [Acute liver failure. Current aspects of diagnosis and therapy].

Authors:  M Bauer; M Paxian; A Kortgen
Journal:  Anaesthesist       Date:  2004-06       Impact factor: 1.041

5.  [The effect of dopexamine and iloprost on plasma disappearance rate of indocyanine green in patients in septic shock].

Authors:  J Birnbaum; C Lehmann; K Taymoorian; D Krausch; H Wauer; M Gründling; C Spies; W J Kox
Journal:  Anaesthesist       Date:  2003-11       Impact factor: 1.041

6.  Heat shock protein 90 is responsible for hyperdynamic circulation in portal hypertensive rats.

Authors:  Jian-Hua Ai; Zhen Yang; Fa-Zu Qiu; Tong Zhu
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.